Log In
Log In
Client Account Access
Equity Research Access
Fixed Income Client Portal
Macro Research Access
Merchant Banking Investor Access
Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy & Power
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
Insights
News
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Read more
about CytokineticsIncorporated-2020-07-21
$201.0 Million
Image
Cytokinetics, Incorporated
Follow-On Offering
Active Bookrunner
Read more
about TCR2Therapeutics-2020-07-31
$142.6 Million
Image
TCR2 Therapeutics
Follow-On Offering
Active Bookrunner
Read more
about TELABioInc-2020-06-25
$48.0 Million
Image
TELA Bio, Inc.
Follow-On Offering
Active Bookrunner
Read more
about OysterPointPharmaInc-2020-05-14
$120.8 Million
Image
Oyster Point Pharma, Inc.
Follow-On Offering
Active Bookrunner
Read more
about AvadelPharmaceuticals-2020-04-28
$125.0 Million
Image
Avadel Pharmaceuticals
Follow-On Offering
Active Bookrunner
Read more
about XerisPharmaceuticalsInc-2020-02-11
$42.7 Million
Image
Xeris Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
Read more
about DecipheraPharmaceuticalsInc-2020-02-13
$201.3 Million
Image
Deciphera Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
Read more
about ArrowheadPharmaceuticalsInc-2019-12-03
$266.8 Million
Image
Arrowhead Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
Read more
about CRISPRTherapeuticsAG-2019-11-20
$315.2 Million
Image
CRISPR Therapeutics AG
Follow-On Offering
Active Bookrunner
Read more
about NextCureInc-2019-11-14
$172.3 Million
Image
NextCure, Inc.
Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 20
Next page
››
Subscribe to Active Bookrunner